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Adverse events continue to be high priorities in healthcare. Reimbursement changes have tied prevention
of adverse events to advancements in health information technology.  Accordingly, early warning systems
have been incorporated into the electronic health record (EHR) of many hospitals.  Although early warning
systems, such as the Rothman Index (RI), address risk identification, no such system has been used to
assess pressure ulcer risk.
This research examined whether the RI would be useful for the prediction of pressure ulcer (PU) risk, PU
presence at discharge, rapid response episode occurrence, and unplanned hospital readmission within 30
days. This study of 7567 adult medical-surgical patients’ less than or equal to 18 years of age was a
secondary analysis of a limited data set from a rural, Midwestern, not-for-profit, community hospital. The
Braden Risk Assessment Scale (BRAS) and RI risk scores upon discharge were strongly correlated. 
Patients discharged with a PU had a longer hospital length of stay, greater frequency of rapid response
episodes (emergent procedures to rescue the patient prior to life-threating episodes), lower BRAS and RI
risk scores, and greater frequency of readmission within 30 days of discharge than those without a PU.
Readmission within 30 days of discharge was associated with PU presence at discharge.  Addressing the
wound care needs of patients admitted with a PU may help decrease hospital length of stay, rapid response
episodes, and hospital readmission rates. The RI may assist in identification of patients at risk for adverse
events, guide healthcare providers in the personalization of the patient’s healthcare experience and improve
healthcare outcomes.
